Latest Breaking News On - Insider activity at kiniksa pharmaceuticals - Page 1 : vimarsana.com

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target Raised to $30.00 at JPMorgan Chase & Co.

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target Raised to $30.00 at JPMorgan Chase & Co.
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China
Michaelr-megna
Sanjk-patel
Victory-capital-management-inc
Sg-americas-securities
Hedge-funds-weigh-in-on-kiniksa-pharmaceuticals
News-ratings-for-kiniksa-pharmaceuticals-daily
Kiniksa-pharmaceuticals-company-profile
Insider-activity-at-kiniksa-pharmaceuticals
Capital-management-inc
Jpmorgan-chase-co

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Reaches New 1-Year High at $20.94

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Reaches New 1-Year High at $20.94
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Johnf-paolini
Mark-ragosa
Securities-exchange-commission
York-mellon-corp
Kiniksa-pharmaceuticals
News-ratings-for-kiniksa-pharmaceuticals-daily
Charles-schwab-investment-management-inc
Tejara-capital-ltd
Kiniksa-pharmaceuticals-ltd
Insider-activity-at-kiniksa-pharmaceuticals
Group-plc
Kiniksa-pharmaceuticals-price-performance